
|Articles|April 1, 2001
- Pharmaceutical Executive-04-01-2001
- Volume 0
- Issue 0
Genentech's Passion for Patients
Author(s)L.J. Sellers
Genentech's sprawling campus overlooking San Francisco Bay seems serene on the surface, but internally, the company resonates with energy.
Advertisement
Articles in this issue
about 25 years ago
Internet DTC - Minding Your P's & Q'sabout 25 years ago
Regulation: Two-Track Planabout 25 years ago
Policy: Tectonic Shiftabout 25 years ago
Liberated?about 25 years ago
A Matter of Tasteabout 25 years ago
Partnerships: Bargaining Biotechsabout 25 years ago
Pediatric Mandateabout 25 years ago
Regulation: OK After AllAdvertisement
Advertisement
Advertisement
Trending on PharmExec
1
Why ‘Fully Staffed’ Field Teams Still Miss Revenue Targets—and How Pharma Can Fix It
2
Pharma M&A Roundup: Ipsen to Acquire Kartos Therapeutics, Zymeworks to Acquire Theravance Biopharma
3
The New Healthy Aging Imperative and What It Means for Pharma
4
EMA’s CHMP Recommends Eli Lilly’s Jaypirca for Approval
5




